Moraleda Redecilla, CintaRabinovich, ReginaAlonso, PedroMenéndez, Clara2018-01-172018-01-172017-12-180002-9637https://hdl.handle.net/2445/119072Anemia is a major public health problem that affects mainly children, predominantly in low-income countries and most often due to iron deficiency (ID). Administration of iron supplements to prevent and treat ID anemia in malaria endemic areas has been controversial for decades; however, recent World Health Organization guidelines recommend universal iron supplementation for children in highly prevalent anemia settings, including those where malaria is endemic. However, infants younger than 6 months of age have been exempted from this recommendation because ID is not considered prevalent at this age and because of assumptions-without evidence-that they are protected from ID through breast milk. To achieve full impact of anemia prevention targeting infants less than 6 months of age who are at highest risk of ID, operational studies that conclusively demonstrate the effectiveness and safety of delivering iron supplements to young infants in settings with a high burden of infectious diseases, including malaria, are needed.6 p.application/pdfengcc by (c) American Society of Tropical Medicine and Hygiene, 2017http://creativecommons.org/licenses/by/3.0/es/AnèmiaInfants nadonsAnemiaNewborn infantsinfo:eu-repo/semantics/article2017-12-27info:eu-repo/semantics/openAccess29260649